258 results on '"Craigo, Sabrina D."'
Search Results
2. Fetal anomalies
3. Identification of micrognathia by prenatal ultrasound may improve timely diagnosis and management of infants with Robin sequence
4. Prenatal presentation of 49,XXXXY syndrome
5. Indicated Preterm Birth for Fetal Anomalies
6. Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers
7. Circulating cell-free DNA levels increase variably following chorionic villus sampling
8. The Patient with Asymptomatic Shortened Cervix at 23 to 28 Weeks: Is Delivery Imminent?
9. Use of array comparative genomic hybridization for prenatal diagnosis of fetuses with sonographic anomalies and normal metaphase karyotype†
10. Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two-vessel cord, and hydrocele
11. Contingent screening for Down syndrome
12. Maternal smoking during pregnancy and false positive maternal serum alpha-fetoprotein (MSAFP) screening for open neural tube defects
13. First- and Second-Trimester Screening: Detection of Aneuploidies Other Than Down Syndrome
14. The Contribution of Birth Defects to Preterm Birth and Low Birth Weight
15. First- and Second-Trimester Evaluation of Risk for Down Syndrome
16. Human Sexual Size Dimorphism in Early Pregnancy
17. Fetal growth in early pregnancy and risk of delivering low birth weight infant: prospective cohort study
18. REPEATED MEASURES SCREENING FOR TRISOMY 21 - RESULTS FROM A GENERAL POPULATION SCREENING TRIAL (THE FASTER TRIAL): 27
19. The association between time of birth and fetal injury resulting in death
20. CONTINGENT SCREENING FOR TRISOMY 21 — RESULTS FROM A GENERAL POPULATION SCREENING TRIAL: 69
21. IS THERE A NUCHAL TRANSLUCENCY MEASUREMENT ABOVE WHICH THERE IS NO ADDED BENEFIT FROM SERUM SCREENING?: 63
22. The association between time of birth and fetal injury resulting in death
23. First-Trimester or Second-Trimester Screening, or Both, for Downʼs Syndrome
24. Ultrasound-guided procedures for prenatal diagnosis and therapy
25. Obesity, obstetric complications and cesarean delivery rate—a population-based screening study
26. MAINTAINING QUALITY ASSURANCE FOR NUCHAL TRANSLUCENCY SONOGRAPHY IN A PROSPECTIVE MULTICENTER STUDY: RESULTS FROM THE FASTER TRIAL
27. FIRST-TRIMESTER NASAL BONE EVALUATION FOR ANEUPLOIDY IN AN UNSELECTED GENERAL POPULATION: RESULTS FROM THE FASTER TRIAL
28. FIRST-TRIMESTER ORIGINS OF FETAL GROWTH IMPAIRMENT AND ITS CONSEQUENCES—RESULTS FROM THE FASTER TRIAL
29. FIRST- AND SECOND-TRIMESTER EVALUATION OF RISK (FASTER) TRIAL: PRINCIPAL RESULTS OF THE NICHD MULTICENTER DOWN SYNDROME SCREENING STUDY
30. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-base screening study (the FASTER trial)
31. 65 FIRST TRIMESTER CYSTIC HYGROMA—A POPULATION BASED SCREENING STUDY (THE FASTER TRIAL)
32. Validation of fetal telemedicine as a new obstetric imaging technique
33. Cervical Incompetence and Preterm Delivery
34. Pregnancy outcomes after prenatal diagnosis of aneuploidy
35. Managing adnexal masses in pregnancy
36. Triplet pregnancy and multifetal reduction: a rational review of the data
37. First-Trimester Cystic Hygroma
38. Role of Second-Trimester Genetic Sonography After Down Syndrome Screening
39. Preconceptional Folate Supplementation and the Risk of Spontaneous Preterm Birth
40. Preconceptional Folate Supplementation and the Risk of Spontaneous Preterm Birth: A Cohort Study
41. Individualized Norms of Optimal Fetal Growth
42. 575: Cell free fetal DNA in maternal circulation after chorionic villus sampling
43. 709: Identifying the pregnant smoker at high risk for preterm birth
44. 121: Extremes of fetal growth are associated with spontaneous preterm birth
45. 569: Array CGH in prenatal diagnosis of fetuses with sonographic anomalies
46. 708: The association between second-trimester inhibin a levels and poor pregnancy outcomes
47. 33: Assessment of risk for fetal loss by maternal characteristics with first and second trimester maternal serum markers
48. Fetal Growth in Early Pregnancy and Risk of Delivering Low Birth Weight Infant: Prospective Cohort Study
49. Pregnancy Loss Rates After Midtrimester Amniocentesis
50. Nuchal Translucency and the Risk of Congenital Heart Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.